Basic Information
TRESIBA® FLEXTOUCH® SOLUTION FOR INJECTION IN PRE-FILLED PEN 100 U/ML
INJECTION, SOLUTION
Regulatory Information
SIN15703P
May 31, 2019
Prescription Only
Therapeutic
SUBCUTANEOUS
August 10, 2023
May 30, 2025
XA10AE06
Company Information
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Active Ingredients
Insulin Degludec
Strength: 100U/ml
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in _List of excipients_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**Therapeutic indications** Treatment of diabetes mellitus in adults and adolescents from the age of 12–17 years.